Clinical effect of a new long-acting preparation of Cephalexin (S-6436 and S-6437) was investigated on patients with infectious diseases in the otolaryngological fields.
S-6436 was administered at the dosis of 500mg b. i.d. and S-6437 at about 25mg/kg b. i.d., and the following results were obtained.
1) Twenty three cases were rated excellent, 9, good, 4, slightly good and 3, poor, the effective rate being 82.1%.
2) As the side effect, rash was observed in one case out of the 40 cases.
3) From above results, it is concluded that S-6436 b. i.d. is eqivalent to Cephalexin q. i.d. in effectiveness and safety for the infectious diseases in the otolaringolgical field.
